Publications
Smith CC, Zwerner IM, Gudjonsson JE, Ward NL. Reevaluating the Imiquimod Model: A Barrier to Translational Progress in Psoriasis. The Journal of investigative dermatology. 2025. PMID: 41143763
Han Z, Lee HY, Yu S, Hsu SH, Fitzgerald KJ, Kann BH, Kozono D, Leeman JE, van Dams R, Mak RH. Ratio of PTV to normal lung volumes as a dosimetric predictor for lung metrics in peripheral lung SBRT. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2025. PMID: 41136250
DeBoer RJ, Uwamahoro P, Ndoli DA, Rugengamanzi E, Mulindabigwi A, Bigirimana JB, Musafiri T, Slater SE, Van Loon K, Sudore RL, Anderson WG, Sanders JJ, Cubaka VK. Adaptation of a serious illness communication training intervention for the Rwandan context. Journal of pain and symptom management. 2025. PMID: 41135916
Goudy L, Ha A, Borah AA, Umhoefer JM, Chow L, Tran C, Winters A, Talbot A, Hernandez R, Li Z, Subramanya S, Arab A, Kale N, Lee JHJ, Muldoon JJ, Liu C, Schmidt R, Santangelo P, Carnevale J, Eyquem J, Shy BR, Marson A, Gilbert LA. Integrated epigenetic and genetic programming of primary human T cells. Nature biotechnology. 2025. PMID: 41120666
Johnston S, Martin M, O'Shaughnessy J, Hegg R, Tolaney SM, Guarneri V, Del Mastro L, Campone M, Sohn J, Boyle F, Cortes J, Rugo HS, Goetz MP, Hamilton EP, Huang CS, Senkus E, Cicin I, Testa L, Neven P, Huober J, Shao Z, Wei R, Munoz M, San Antonio B, Shahir A, Rastogi P, Harbeck N. Overall survival with abemaciclib in early breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2025. PMID: 41110697
Suresh A, Pan D, Lipof J, Kumar A, Arora S, Sayre P, Wolf J, Martin T, Chari A, Chung A. How should we choose optimal salvage treatments following BCMA-directed CAR T-cell therapy? Immunotherapy. 2025. PMID: 41104991
Avigan ZM, Catlett J, Bodnar S, Pan D, Aleman A, Sheng T, Moshier E, Rossi AC, Richard S, Kaur G, Richter J, Sanchez LJ, Rodriguez C, Cho HJ, Hussein S, Salib C, Silverman LR, Jagannath S, Parekh S, Thibaud S. Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025. PMID: 40801897
Zhu L, Cheung YM, Chiang C, Gallagher EJ, Hamnvik OR, Mammen J, Quandt Z, Jones R, McDunn J, Al-Bahadili H, Angell T, Bancos I, Betof Warner A, Blackwell S, Calabrese C, Cho TA, Dougan M, Ferreira M, Funchain P, Herndon J, Johnson DB, Kennedy R, Kheterpal M, Khouri M, Lechner MG, Lim AM, Markova A, Meara A, Overton L, Perdigoto AL, Sachithanandan N, Sharon E, Spain L, Tsai K, Yarchoan M, Reynolds KL, Shariff A. Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors. Journal for immunotherapy of cancer. 2025. PMID: 41093625
Chowdhury S, Gasper C, Lazar AA, Allaire K, Darragh TM, Fong L, Palefsky JM. Expression of Programmed Death-Ligand 1 and Programmed Cell Death-1 Across the Anal Neoplasia Disease Continuum and Association With Survival in Anal Cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2025. PMID: 41106476
Woodard GA, Kramer RJ, Blakely CM. Neoadjuvant Tyrosine Kinase Inhibitors. Thoracic surgery clinics. 2025. PMID: 41260725
Jaishankar P, Correy GJ, Matsui Y, Togo T, Rachman MM, Stevens MGV, Hantz ER, Zheng J, Diolaiti ME, Montano M, Taha TY, Rosecrans J, Pampel J, Krogan NJ, Shoichet BK, Ashworth A, Ott M, Fraser JS, Renslo AR. Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy in vivo. bioRxiv : the preprint server for biology. 2025. PMID: 41279160
Ebadi M, Fan X, Schoch G, Gooley T, Rashidi A, Smith SD, Shadman M, Holmberg L, Ujjani C, Poh C, Raghunathan V, Ali N, Vo PT, Manjappa S, Menon M, Di M, Lynch R, Ho C, Till BG, Ermoian R, Gopal AK, Tseng YD. Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Haematopoietic Stem Cell Transplantation for Relapsed/Refractory Large B-cell Lymphoma. Clinical oncology (Royal College of Radiologists (Great Britain)). 2025. PMID: 41172559
Finn RS, Rugo HS, Cortes J, Loibl S, Foley G, Gauthier E, Wang Y, Kim S, Anders L, Slamon DJ. A Decade After Approval of the First CDK4/6 Inhibitor: A Look Back at Palbociclib's Journey from Discovery to Approval and What's Next in CDK Inhibition in Breast Cancer. Targeted oncology. 2025. PMID: 41087648
Gelmon K, Villarreal-Garza C, Aubel D, S Rugo H, Maués J, Travado L, Van Meerveld M, C W Chidebe R, Patel B, Attfield G, Lewis A, Cardoso F. Improving the quality of life of people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (goal 3). Breast (Edinburgh, Scotland). 2025. PMID: 41298008
Kiely B, Travado L, Smith AL, Timeus IA, Kim SB, Haidinger R, N M Nanre N, Rugo H, Attfield G, Lewis A, Cardoso F. Increasing awareness of and referral to support services in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 7). Breast (Edinburgh, Scotland). 2025. PMID: 41298009
Shah NJ, Shinde R, Bhattacharya R, LeMasters T, Ning N, Schmier J, Tan M, Vickery D, Perini R, Motzer RJ. Postimmunotherapy and Vascular Endothelial Growth Factor Inhibitor Landscape in Advanced Renal Cell Carcinoma: Treatment Patterns, Costs, and Outcomes. JCO oncology practice. 2025. PMID: 41082704
Oseran AS, Aggarwal R, Wadhera RK. Cardiovascular Risk Factor Management in Medicare Advantage and Traditional Medicare. Circulation. Cardiovascular quality and outcomes. 2025. PMID: 41064875
Manabe T, Bergo HC, Li Q, Wang TS, Severson P, Miller N, Lee C, Donderici EY, Zhang N, Wu W, Chou YT, Kerr DL, Allegakoen P, Grandinetti KB, Soroceanu L, Pelham RJ, Martin ES, Murphy EA, Khanna V, Neal JW, Chen CT, Kato S, Williams R, Bivona TG. Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies. Research square. 2025. PMID: 41282105
Bardossy ES, Bergmann L, Henrion-Lacritick A, Nigg J, Correy GJ, Ashworth A, Fraser JS, Saleh MC. Macrodomain ADP-ribose binding but not ADP-ribosylhydrolase activity is critical for chikungunya virus infection of Aedes mosquitoes. bioRxiv : the preprint server for biology. 2025. PMID: 41279946
Burstein HJ, Curigliano G, Gnant M, Loibl S, Regan MM, Loi S, Denkert C, Poortmans P, Cameron D, Thurlimann B, Weber WP, Panelists of the St. Gallen International Breast Cancer Consensus 2025. Electronic address: https://, Panelists of the St. Gallen International Breast Cancer Consensus 2025. Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2025. PMID: 41072918